SMC4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.959800E-01
Normal-vs-Stage2
8.566400E-01
Normal-vs-Stage3
3.631200E-01
Normal-vs-Stage4
7.250800E-01
Stage1-vs-Stage2
6.184600E-01
Stage1-vs-Stage3
3.107000E-01
Stage1-vs-Stage4
5.363200E-01
Stage2-vs-Stage3
1.191830E-01
Stage2-vs-Stage4
5.256600E-01
Stage3-vs-Stage4
2.521800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.265000E-01
Normal-vs-AfricanAmerican
9.965800E-01
Normal-vs-Asian
7.196200E-01
Caucasian-vs-AfricanAmerican
8.905600E-01
Caucasian-vs-Asian
4.425200E-01
AfricanAmerican-vs-Asian
6.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.919600E-01
Normal-vs-Female
8.573200E-01
Male-vs-Female
4.489200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.694000E-01
Normal-vs-Age(41-60Yrs)
6.360200E-01
Normal-vs-Age(61-80Yrs)
9.051800E-01
Normal-vs-Age(81-100Yrs)
9.418600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.498160E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.965800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.574400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.213800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.980000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.570200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.779200E-01
Normal-vs-Daily Drinker
7.084000E-01
Normal-vs-Weekly Drinker
9.900400E-01
Normal-vs-Occasional Drinker
6.506400E-01
Normal-vs-Social Drinker
7.151000E-01
Non Drinker-vs-Daily Drinker
6.546200E-01
Non Drinker-vs-Weekly Drinker
7.979000E-01
Non Drinker-vs-Occasional Drinker
1.812350E-01
Non Drinker-vs-Social Drinker
2.869000E-01
Daily Drinker-vs-Weekly Drinker
5.377200E-01
Daily Drinker-vs-Occasional Drinker
9.954000E-02
Daily Drinker-vs-Social Drinker
1.559020E-01
Weekly Drinker-vs-Occasional Drinker
3.967200E-01
Weekly Drinker-vs-Social Drinker
5.150800E-01
Occasional Drinker-vs-Social Drinker
8.261000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.373200E-01
Normal-vs-Grade 2
8.895000E-01
Normal-vs-Grade 3
9.496600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.042200E-04
Grade 1-vs-Grade 3
4.31539999999897E-05
Grade 1-vs-Grade 4
7.373200E-01
Grade 2-vs-Grade 3
1.344600E-01
Grade 2-vs-Grade 4
8.895000E-01
Grade 3-vs-Grade 4
9.496600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.217200E-01
Normal-vs-NonDiabetic
9.178000E-01
Diabetic-vs-NonDiabetic
1.440170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.972400E-01
Normal-vs-NoPancreatitis
9.926400E-01
Pancreatitis-vs-NoPancreatitis
8.470400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.849200E-01
Normal-vs-N1
8.615800E-01
N0-vs-N1
4.937600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.048800E-01
Normal-vs-TP53-NonMutant
9.439800E-01
TP53-Mutant-vs-TP53-NonMutant
1.8934199999987E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
